arrow
Return

Low-power selective pattern compression for scan-based test applications

delete2014-05-01
delete8
PRE
AI
S
S. Sivanantham
P
P. S. Mallick *
J
J. Raja Paul Perinbam
DOI:10.1016/j.compeleceng.2013.11.028delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The ever-increasing test data volume and test power consumption are the two major issues in testing of digital integrated circuits. This paper presents an efficient technique to reduce test data volume and test power simultaneously. The pre-generated test sets are divided into two groups based on the number of unspecified bits in each test set. Test compression procedure is applied only to the group of test sets which contain more unspecified bits and the power reduction technique is applied to the remaining test sets. In the proposed approach, the unspecified bits in the pre-generated test sets are selectively mapped with Os or is based on their effectiveness in reducing the test data volume and power consumptions. We also present a simple decoder architecture for on-chip decompression. Experimental results on ISCAS'89 benchmark circuits demonstrate the effectiveness of the proposed technique compared with other test-independent compression techniques. (C) 2013 Elsevier Ltd. All rights reserved.
Keywords:
TEST DATA VOLUME
RUN-LENGTH
SYSTEM
ARCHITECTURE
CAPTURE
SCHEME
SHIFT
TIME
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

C
Computers and Electrical Engineering
IF:
4.9
Papers:
6.7K
Citations:
1.3W

Organization

V
vit vellore
Scholars:
4.5K
Papers: 4.6K
Citations: 0
Cited Papers

Cited Papers

Role of Foxp3+regulatory T cells in chronic ethanol consumption and sepsis pathogenesis
errALCOHOL
IF2.9
err2024-12-01
err0
PREAI
errGutierrez, M. B.; Coopersmith, C. M.; Ford., M. L.
errShare
errSave
LONG-TERM EVALUATION OF LIVER HEALTH IN PARTICIPANTS WHO RECEIVED FIDANACOGENE ELAPARVOVEC: DATA FROM A PHASE 1/2A STUDY WITH UP TO 6 YEARS OF FOLLOW UP
err2024-12-01
err0
PREAI
errDucore, Jonathan; George, Lindsey A.; Samelson-Jones, Ben J.; Rasko, John; McGuinn, Catherine; Giermasz, Adam; Teitel, Jerome; High, Katherine; Rupon, Jeremy; Fang, Annie; Smith, Lynne; Patel, Priya; Chhabra, Amit; Plonski, Frank; Kalac, Matko
errShare
errSave
USING A THROMBODYNAMICS TEST FOR DIAGNOSTICS OF HYPERCOAGULATION IN CANCER PATIENTS AND PREDICTION OF THROMBOEMBOLIC COMPLICATIONS: PRELIMINARY RESEARCH RESULTS
err2024-12-01
err0
PREAI
errDudina, Irina; Koltsova, Ekaterina; Nigmatullina, Irina; Akhmadiyarova, Yana; Kostash, Olga; Chankina, Anna; Stroyakovskiy, Daniil
errShare
errSave
ACCURACY OF A WARFARIN CLINICAL DOSING ALGORITHM ENRICHED WITH GENETIC INFORMATION COMPARED TO THE USE OF CLINICAL ALGORITHM
err2024-12-01
err0
PREAI
errFahmi, Amr; El Bardissy, Ahmed; Saad, Mohamed; Nabil, Mohamed; Bader, Loulia; Kassem, Mohamed; Mahfouz, Ahmed; Elewa, Hazem
errShare
errSave
IMMUNOTHROMBOSIS AND SEPTICEMIA
err2024-12-01
err0
PREAI
errFox-Robichaud, Alison
errShare
errSave
Alcohol-induced reduction of circulating liver-expressed antimicrobial peptide, LEAP2: implications for alcohol-associated liver disease pathogenesis
errALCOHOL
IF2.9
err2024-12-01
err0
PREAI
errEthiraj, O.; Mahalingam, S.; Bellamkonda, R.; Casey, C. A.; Kharbanda, K. K.; Rasineni, K.
errShare
errSave
researcher View more